Koers Allied Corp. Other OTC
Aandelen
ALID
US0191141078
Farmaceutische producten
Omzet 2022 | 0,17 0,15 | Omzet 2023 | 0,07 0,07 | Marktkapitalisatie | 22,78 mln. 21,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -15 mln. -14,03 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,35 mln. | EV/omzet 2022 | 289.040.315 x |
Nettoschuld 2022 | 4,98 mln. 4,66 mln. | Nettoschuld 2023 | 5,65 mln. 5,29 mln. | EV/omzet 2023 | 394.366.816 x |
K/w-verhouding 2022 |
-2,73
x | K/w-verhouding 2023 |
-2,13
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 50,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Calum Hughes
CEO | Chief Executive Officer | - | - |
Ryan Maarschalk
DFI | Director of Finance/CFO | 42 | 25-03-20 |
Radka Milanova
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Smeeding
BRD | Director/Board Member | - | 02-05-20 |
Calum Hughes
CEO | Chief Executive Officer | - | - |
David Weinkauf
PRN | Corporate Officer/Principal | 56 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
+0,09% | 1,65 mld. | |
-7,89% | 1,68 mld. | |
-12,97% | 1,53 mld. | |
+33,40% | 1,38 mld. |